Delirium Tremens (DT): ICU Patient Care and Treatment

What it is and why it's an emergency

1. Immediate assessment on admission/recognition

• Confirm diagnosis and rule out mimics/comorbid causes: hypoglycemia, head injury, CNS infection, hepatic encephalopathy, other drug intoxication/withdrawal (Tintinalli's Emergency Medicine).
• Use a validated scale to grade severity and guide dosing: CIWA-Ar (Clinical Institute Withdrawal Assessment for Alcohol-Revised) - score >15 needs hourly dosing, 8-14 needs 2-hourly dosing, and a score >10 generally prompts active pharmacologic management (Tintinalli's; Symptom to Diagnosis).
• Risk factors that predict progression to DT: prior seizures/DT, long duration/high volume of drinking, older age, concurrent illness, low K+/Mg2+, thiamine deficiency, inadequately treated withdrawal (Maudsley Guidelines).
• Transfer to ICU/high-dependency setting is required once DT is established - this is a medical emergency (Maudsley).

2. Pharmacologic management (core of ICU treatment)

• Goal: rapid control of agitation to achieve light somnolence, arousable to stimulation (target RASS 0 to -2, or Riker SAS 3-4).
• IV lorazepam or diazepam, using an escalating-dose, symptom-triggered protocol: doses are doubled/escalated every 10-20 minutes until the sedation goal is reached, then the effective dose becomes the basis for scheduled maintenance dosing (boluses or continuous infusion) (Tintinalli's Emergency Medicine; Medscape).
• Typical escalation: diazepam IV up to 100-150 mg/dose (or lorazepam IV up to 30-40 mg/dose) with reassessment after each dose.
• IM diazepam is not recommended (erratic absorption); IM lorazepam/midazolam is acceptable if IV access is unavailable.
• No single benzodiazepine has proven superior; choice depends on institutional protocol, hepatic function, and route availability.

• Defined roughly as failure to achieve control despite 50-100 mg diazepam or 10-20 mg lorazepam in the first hour, or the "≥200 mg diazepam in 3 hours / ≥400 mg in 8 hours" thresholds cited in the literature.
• Add phenobarbital (first-choice adjunct) - IV 65-260 mg repeated doses (some protocols use 130-260 mg every 15-20 min, max ~1040 mg/24h) titrated to symptom control. Phenobarbital has GABAergic action independent of benzodiazepine receptors and is associated with reduced need for mechanical ventilation and shorter ICU stay in retrospective cohorts.
• If still uncontrolled: propofol or dexmedetomidine infusion - these essentially always require intubation and mechanical ventilation.
  • Propofol risk: hypotension; and propofol infusion syndrome if >48h at >5 mg/kg/hr (arrhythmias, heart failure, hyperkalemia, lipemia, metabolic acidosis, rhabdomyolysis).
• Haloperidol/antipsychotics: can be added for hallucinations/agitation but used cautiously - they lower seizure threshold and can prolong QTc, so check ECG and electrolytes (K+, Mg2+) before use. Not preferred as monotherapy for DT.

3. Essential supportive/ICU nursing care

• Thiamine 100-500 mg IV before any glucose-containing fluids (prevent/treat Wernicke encephalopathy) - continue until symptoms resolve; add folate.
• Correct electrolytes: hypokalemia, hypomagnesemia, hypophosphatemia are common and worsen arrhythmia/seizure risk.
• Fluid and metabolic monitoring - DT causes life-threatening fluid and electrolyte imbalance; monitor for dehydration, hypoglycemia.
• Seizure precautions: benzodiazepines also treat/prevent withdrawal seizures (lorazepam 2 mg IV is a standard dose); phenytoin is NOT effective for alcohol withdrawal seizures and should be avoided.
• Continuous cardiac and hemodynamic monitoring given autonomic instability (tachycardia, hypertension, hyperthermia).
• Aspiration precautions, treatment of hyperthermia, and thorough workup/treatment of co-occurring illness (infection, trauma, pancreatitis, etc. often precipitate or complicate DT).
• Frequent reassessment with CIWA-Ar or sedation scores (RASS/RSAS) to titrate therapy and avoid over/under-sedation.
• Low-stimulation environment, reorientation, and one-to-one nursing/frequent observation given fall and self-harm risk from agitation and hallucinations.
• Plan for mechanical ventilation readiness if phenobarbital/propofol are used at doses causing respiratory depression.

4. Summary treatment ladder

1. Uncomplicated withdrawal: oral benzodiazepine (lorazepam, diazepam, chlordiazepoxide, or oxazepam).
2. Withdrawal seizures: IV lorazepam/diazepam (not phenytoin).
3. Delirium tremens: IV benzodiazepine escalating/symptom-triggered dosing to light somnolence.
4. Refractory DT: add phenobarbital (preferred adjunct) → propofol or dexmedetomidine (requires intubation) ± cautious haloperidol for hallucinations.
5. Throughout: thiamine, electrolyte repletion, hemodynamic/cardiac monitoring, treat comorbid conditions.

Thiamine Administration in Delirium Tremens / Alcohol Withdrawal

Why the sequence matters

Exception: if the patient has life-threatening hypoglycemia, don't withhold emergency glucose to wait for thiamine - give them together/simultaneously rather than delaying glucose (Medscape).

Route and dose

Practical administration points

• Give thiamine 100 mg IV (or higher-dose regimens up to 500 mg IV) before/with the first bag of dextrose-containing IV fluid in any patient with suspected thiamine deficiency (alcohol use disorder, malnutrition, decompensated liver disease).
• Dilute in a small volume of saline/dextrose-free fluid and infuse slowly (over 10-30 minutes) as IV thiamine has a small anaphylaxis risk - have resuscitation facilities available, especially with the first dose.
• IM injection is a reasonable alternative if IV access is difficult, and is standard for community/outpatient prophylaxis.
• Continue daily thiamine dosing until clinical improvement, then step down to oral maintenance (100 mg/day is a commonly used oral continuation dose) once the patient is eating/absorbing normally.
• Co-administer with magnesium: magnesium is a required cofactor for thiamine-dependent enzymes, so hypomagnesemia blunts the response to thiamine. Check and replete magnesium (and other electrolytes like potassium, phosphate) alongside thiamine dosing (Rosen's Emergency Medicine).
• Folate supplementation is often given concurrently as part of general nutritional repletion in chronic alcohol use, though it doesn't substitute for thiamine.
• Always take a thorough nutritional/alcohol history and monitor for emergent signs of Wernicke encephalopathy (confusion, ataxia, oculomotor abnormalities - nystagmus/ophthalmoplegia) daily during treatment; if these appear, escalate to high-dose IV thiamine and transfer to a setting where this can be delivered safely.

Bottom line sequence for ICU/DT patients

1. IV thiamine (100-500 mg depending on protocol/suspicion of Wernicke)
2. THEN or WITH glucose-containing fluids (never glucose alone first)
3. PLUS magnesium and potassium repletion
4. Continue thiamine daily for 3-5+ days, then transition to oral maintenance